Krista M. La Perle, Ph.D.
Affiliations: | 2002 | Ohio State University, Columbus, Columbus, OH |
Area:
Pathology, Oncology, Cell BiologyGoogle:
"Krista La Perle"Mean distance: 6635.5
Parents
Sign in to add mentor| Sissy M. Jhiang | grad student | 2002 | Ohio State | |
| (Characterization of ret/PTC1 transgenic-p53 knockout mice and sodium /iodide symporter gene transfer for prostate cancer.) | ||||
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Bowman RL, Hennessey RC, Weiss TJ, et al. (2021) UVB mutagenesis differs in - and -mutant mouse models of melanoma. Life Science Alliance. 4 |
| Saji M, Kim CS, Wang C, et al. (2020) Akt isoform-specific effects on thyroid cancer development and progression in a murine thyroid cancer model. Scientific Reports. 10: 18316 |
| Knippler CM, Saji M, Rajan N, et al. (2019) MAPK- and AKT-activated thyroid cancers are sensitive to group I PAK inhibition. Endocrine-Related Cancer |
| Huk D, Ashtekar A, Magner A, et al. (2018) Deletion of Rap1b, but not Rap1a or Epac1, reduces PKA-mediated thyroid cancer. Thyroid : Official Journal of the American Thyroid Association |
| Relation T, Yi T, Guess AJ, et al. (2018) Intratumoral Delivery of Interferon γ-secreting MSCs Repolarizes Tumor-Associated Macrophages and Suppresses Neuroblastoma Proliferation In Vivo. Stem Cells (Dayton, Ohio) |
| Tsai YT, Lakshmanan A, Lehman A, et al. (2017) BRAFV600E accelerates disease progression and enhances immune suppression in a mouse model of B-cell leukemia. Blood Advances. 1: 2147-2160 |
| Ashtekar A, Huk D, Magner A, et al. (2017) Sdhd ablation promotes thyroid tumorigenesis by inducing a stem-like phenotype. Endocrine-Related Cancer |
| Comiskey DF, Jacob AG, Sanford BL, et al. (2017) A novel mouse model of rhabdomyosarcoma underscores the dichotomy of MDM2-ALT1 function in vivo. Oncogene |
| Wang C, Saji M, Justiniano SE, et al. (2017) RCAN1-4 is a thyroid cancer growth and metastasis suppressor. Jci Insight. 2: e90651 |
| Karras JR, Schrock MS, Batar B, et al. (2016) Fhit loss-associated initiation and progression of neoplasia in vitro. Cancer Science |